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Abstract
Background: Previous analyses of sera from a limited number of Ghanaian Buruli ulcer (BU) patients, their household
contacts, individuals living in BU non-endemic regions as well as European controls have indicated that antibody responses
to the M. ulcerans 18 kDa small heat shock protein (shsp) reflect exposure to this pathogen. Here, we have investigated to
what extent inhabitants of regions in Ghana regarded as non-endemic for BU develop anti-18 kDa shsp antibody titers.
Methodology/Principal Findings: For this purpose we determined anti-18 kDa shsp IgG titers in sera collected from healthy
inhabitants of the BU endemic Densu River Valley and the Volta Region, which was so far regarded as BU non-endemic.
Significantly more sera from the Densu River Valley contained anti-18 kDa shsp IgG (32% versus 12%, respectively).
However, some sera from the Volta Region also showed high titers. When interviewing these sero-responders, it was
revealed that the person with the highest titer had a chronic wound, which was clinically diagnosed and laboratory
reconfirmed as active BU. After identification of this BU index case, further BU cases were clinically diagnosed by the Volta
Region local health authorities and laboratory reconfirmed. Interestingly, there was neither a difference in sero-prevalence
nor in IS2404 PCR positivity of environmental samples between BU endemic and non-endemic communities located in the
Densu River Valley.
Conclusions: These data indicate that the intensity of exposure to M. ulcerans in endemic and non-endemic communities
along the Densu River is comparable and that currently unknown host and/or pathogen factors may determine how
frequently exposure is leading to clinical disease. While even high serum titers of anti-18 kDa shsp IgG do not indicate active
disease, sero-epidemiological studies can be used to identify new BU endemic areas.
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Introduction
Buruli ulcer (BU), a severe necrotizing skin disease, is caused by
the environmental pathogen Mycobacterium ulcerans (M. ulcerans).
Globally, it is the third most prevalent mycobacterial disease that
affects immunocompetent individuals after tuberculosis and
leprosy [1]. Currently more than 30 countries, mainly in the
Tropics and sub-Tropics, are known to report BU cases [2]. The
main countries that are severely affected lie along the Gulf of
Guinea and include Ivory-Coast, Ghana, Togo, Benin and
Cameroon. In the highly endemic countries BU is second after
tuberculosis as the most prevalent mycobacterial disease [2,3].
However, the global burden of BU is not clear, because efficient
and comprehensive reporting systems are lacking in many of the
BU endemic countries. One characteristic of BU is its focal
distribution within highly endemic countries. Most cases occur in
remote villages with limited access to the formal health sector,
prompting affected people to seek health at traditional healers [4].
Even today, not all affected communities may be known to the
National BU Control Programs. Therefore reliable tools to detect
and monitor the presence of BU in communities are urgently
needed.
The disease presentation, which varies between individuals,
starts either as a papule, nodule, plaque or edema and if these non-
ulcerative early forms are not treated, extensive tissue destruction
leads to the formation of large ulcerative lesions with characteristic
undermined borders. Extensive tissue destruction frequently
causes disfigurement and long lasting deformities such as loss of
limbs and essential organs, like the eye [5,6]. Many features of BU
such as the mode of M. ulcerans transmission and risk factors for an
infection with the pathogen are not clearly understood. However,
BU is known to occur mainly in children less than 15 years of age
www.plosntds.org 1 January 2012 | Volume 6 | Issue 1 | e1460
and affects people in wetlands and disturbed environments [3,7].
The pathology of BU is primarily associated with the secretion of
the cytocidal and immunosuppressive polyketide toxin mycolac-
tone [8].
Current methods for a laboratory confirmation of clinical BU
diagnosis include microscopic detection of acid fast bacilli (AFB),
culture of M. ulcerans, histopathology and detection of M. ulcerans
DNA by PCR. Currently, PCR detection of the M. ulcerans specific
insertion sequence IS2404 is the gold standard for BU diagnosis
[9]. Yet, PCR requires elaborate infrastructure and expertise and
therefore make it out of reach for primary health care facilities in
BU endemic low resource countries. Serology represents a more
attractive approach for the development of a simple test format
that can be applied to facilities treating BU in low resourced
countries. Unfortunately, various studies have shown that
serological tests targeting M. ulcerans antigens are not suitable to
differentiate between patients and exposed but healthy individuals
as both groups may exhibit serum IgG titers against these antigens
[10,11]. However, serology may be a useful tool for monitoring
exposure of populations to M. ulcerans, although great antigenic
cross reactivity between M. ulcerans, M. tuberculosis, BCG and other
environmental mycobacteria complicates this approach. We
previously profiled an immunodominant 18 kDa small heat shock
protein (shsp) absent from M. tuberculosis and M. bovis as a suitable
target antigen for sero-epidemiological studies. In spite of the
presence of sequence homologues in M. leprae and M. avium,
Western blot analyses, using a limited number of sera indicated
that this protein can be used to distinguish between M. ulcerans
exposed and non-exposed populations [10]. Here we have
extended these studies with larger sets of sera. These sero-
epidemiological studies identified a BU index case in a region of
Ghana that was regarded, so far, as BU non-endemic.
Materials and Methods
Ethics statement
Ethical clearance for the study was obtained from the institutional
review board of the Noguchi Memorial Institute for Medical
Research (Federal-wide Assurance number FWA00001824). Writ-
ten informed consent was obtained from all individuals involved in
the study. Parents or guardians provided written consent on behalf
of all child participants.
Study area
One part of this study was conducted in five districts of the
Eastern Region including East-Akim (EA), New-Juaben (NJ),
Suhum-Kraboa-Coaltar (SHC), Akwapim South (AS) and Akwa-
pim North (AN) as well as two districts of the Greater-Accra
Region comprising Ga-West (GW) and Ga-South (GS). While EA
and NJ report no BU cases and AN only occasionally, the
remaining four districts have communities that report BU
regularly to the NBUCP. GW reports the highest number of
cases with an annual average number of 100 new cases, followed
by AS, GS and the SKC. This study focused on selected
communities within these districts, which are all located along
the Densu River.
The other part of this study was carried out in three
communities of the Volta Region, namely Torgorme, Gblornu
and Kasa. These communities are situated along the banks of
River Volta in the North Tongu district of the Volta Region,
which was so far regarded as BU non-endemic. Torgorme,
Gblornu and Kasa have an estimated population of about a 1700,
350 and 160, respectively.
Confirmation of BU endemicity in communities along the
Densu River
Initial community entry was done by first meeting community
opinion leaders, which included the disease control officer
responsible for the area, the assembly man and chiefs in order
to explain the importance of the activity and to solicit their
cooperation. A rough sketch and count of houses along the length
and breadth of the community was carried out by walking through
the community in order to estimate an approximate number of
houses to be surveyed. The area was then divided into two blocks,
with one research team being responsible for one block. Each
habitable structure within a block was then numbered serially. A
house to house survey was carried out and interviews involving the
head of a house were done. A data collection chart was used to
collect information on the number of people in the house, healed
and active BU cases and if active cases were found, samples were
collected for confirmation of BU. Collected data of the BU
patients included age and sex, when the disease was contracted
and GPS coordinates of their houses.
Participants and sampling for serological analysis
Two milliliters of blood were collected into vacutainer tubes
(BD) from participants of ten different villages within a 5 km
radius along the Densu River; six and four of the communities
were confirmed as BU endemic and non-endemic, respectively,
using active search and mapping activities as described above. The
endemic communities were: Kojo-Ashong and Otuaplem in the
GW, Kwame Anum and Ayitey Kortor in the GS, Sakyikrom and
Tetteh Kofi in the AS district, respectively. The non-endemic
communities were Obuotumpan and Abotanso in the NJ and
Abesim Yeboah and Ntabea in the EA district. The study
participants aged between 5 and 90 years recruited from these
communities were individuals with no history of BU. 188
participants were from the non-endemic villages (94 each females
and males); age range 5–84 years, arithmetic mean of 28.6 years,
median 19 years and mode of 15. 294 participants were from
endemic villages (139 and 155 were male and females,
respectively); age range 5–90 years, mean age of 26.8 years,
median 20 and mode 12 years.
In addition, whole blood samples were also collected from 99
community members in three villages along the Volta River in the
Volta Region which has so far been considered one of the
Author Summary
Sero-epidemiological analyses revealed that a higher
proportion of sera from individuals living in the Buruli
ulcer (BU) endemic Densu River Valley of Ghana contain
Mycobacterium ulcerans 18 kDa small heat shock protein
(shsp)-specific IgG than sera from inhabitants of the Volta
Region, which was regarded so far as BU non-endemic.
However, follow-up studies in the Volta Region showed
that the individual with the highest anti-18 kDa shsp-
specific serum IgG titer of all participants from the Volta
Region had a BU lesion. Identification of more BU patients
in the Volta Region by subsequent active case search
demonstrated that sero-epidemiology can help identify
low endemicity areas. Endemic and non-endemic commu-
nities along the Densu River Valley differed neither in sero-
prevalence nor in positivity of environmental samples in
PCR targeting M. ulcerans genomic and plasmid DNA
sequences. A lower risk of developing M. ulcerans disease
in the non-endemic communities may either be related to
host factors or a lower virulence of local M. ulcerans strains.
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non-endemic regions in Ghana. The three communities Tor-
gorme, Gblornu and Kasa were selected as having never reported
leprosy in the past five years according to data of the North Tongu
District Directorate of Health Services.
Blood samples were transported immediately at ambient
temperature to the laboratory for separation of serum by
centrifugation at 2,000 g for 10 mins to remove the clot. Sera
were stored at 280uC until analysis.
Western blot analysis
25 mg of recombinant M. ulcerans 18 kDa shsp protein was
separated on NuPAGEH Novex 4–12% Bis-Tris ZOOMTM Gels,
1.0 mm IPG well (Invitrogen) using NuPAGE H MES SDS
Running Buffer (Invitrogen) under reducing conditions and
transferred to nitrocellulose membranes. Membranes were
blocked with 5% skim milk in phosphate-buffered saline (PBS),
0.1%Tween 20 (PBS-T) and cut into strips. Protein strips were
incubated with serum samples at a 1:500 dilution in PBS-T for
1.5 hrs. Strips were washed with 0.3 M PBS, 1% Tween 20 and
incubated with alkaline phosphatase-conjugated AffiniPure F(ab9)2
fragment goat anti-human immunoglobulin G (IgG, Milian). Nitro
blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phos-
phate (BCIP) (BioRad) were used for color development.
ELISA
96-well Nunc-Immuno Maxisorp plates (Thermo Scientific)
were coated with 0.5 mg recombinant 18 kDa shsp per well in
100 ml PBS. Plates were incubated at 4uC overnight. Plates were
washed with dH2O, 2.5% Tween 20 (dH2O-T) and blocked for
1 h with 200 ml blocking buffer (5% skim milk in PBS) at 37uC.
Serial 2-fold dilutions of serum from 1:100 to 1:12800 in 50 ml
blocking buffer per well were incubated for 1.5 hrs at 37uC. The
wells were washed with dH2O-T. 50 ml of 1:6000 diluted goat anti-
human IgG (c-chain specific) coupled to horseradish Peroxidase
(HRP, SouthernBiotech) was added to each well and incubated for
1 h at room temperature. After the last washing step with dH2O-
T, 100 ml TMB Microwell Peroxidase Substrate (KPL) was added.
The reaction was stopped after 5 min. The absorbance was mea-
sured using an ELISA plate reader (Sunrise, Tecan) at 450 nm.
Each ELISA plate contained two-fold dilutions of a negative
control comprising a pool of 5 negative sera from people living in
BU non-endemic communities in Ghana and a positive control
consisting of 5 medium positive sera from people living in BU
endemic areas. The cut-off value for positivity was considered to
be the mean optical density (OD) of negative and positive control
at a 1:100 serum pool dilution. Statistically, data were analyzed
using GraphPad Prism version 5.0 (GraphPad Software, San
Diego California USA). The nonparametric Kruskal-Wallis test
with Dunn’s post-test was used to compare OD values for the
different groups.
PCR analysis of environmental samples
Sampling was done from aquatic environments and from
communities. Water, insects, fish, snails, dominant vegetation
(both dead and living) and soil were collected randomly from the
ground and edges of rivers at various locations in both endemic
and non-endemic communities. Soil, vegetation and animal
droppings were collected from various locations within both
endemic and non-endemic communities. All collected samples
were transported on the same day to the laboratory, stored at 4uC
and analyzed within a week of collection.
DNA was extracted from about 200 mg portions of all the
environmental samples using the FastDNA Spin kit for soil (MP
Biomedical) according to the manufacturer’s instruction. For
insect samples additionally glass beads were added to the lysing
matrix and the breaking step with the Fast Prep instrument was
substituted by heating specimens at 95uC for twenty minutes
followed by vortexing full speed for two minutes. The extracted
DNA was stored at 220uC until analysis by real-time PCR.
TaqMan real-time PCR was performed using primers and
procedures as previously described with some modifications in
reaction conditions [12]. The primers and TaqMan MGB probes
detecting IS2404, IS2606 and the ketoreductase (KR) domain
were obtained from Applied Biosystems (Foster City, CA, USA).
IS2404 real-time PCR mixtures contained 1X Qiagen master mix
(containing HotstarTaq plus DNA polymerase, dNTP mix and
PCR buffer) 1 ml of extracted template DNA, 0.5 mM concentra-
tions of each primer and 0.2 mM probe, 16TaqMan exogenous
internal positive control (IPC) and probe reagents (Applied
Biosystems), in a total volume of 20 ml. Amplification and
detection were performed with the Rotor-Gene Q (Qiagen) using
the following program: 1 cycle of 95uC for 5 min, 40 cycles of
95uC for 15 s and 60uC for 15 s. Each PCR run contained 2 non-
template controls and an IS2404 positive control. Analysis for
IS2606 and KR was in a multiplex PCR using KR and IS2606
probes with FAM and VIC fluorescence labels respectively and
reaction conditions as above.
Data analysis
Initial BU survey results were entered in Microsoft Access and
exported for integration using Quantum Geographic Information
System (GIS) for analyses. Google Earth aerial images of
communities were obtained, geo-referenced and linked to ground
contours, features and other characteristics. The prevalence of BU
was calculated by counting all individuals in the community with a
classical BU scar, together with those with laboratory confirmed
active disease, divided by the total number of persons examined
within a community. The rate was expressed as a percentage.
Results
M. ulcerans 18 kDa shsp specific serum IgG responses in
individuals living in the Volta region of Ghana and
identification of a BU index case in the region
We determined M. ulcerans 18 kDa shsp-specific serum IgG
titers in 482 sera from people living in the BU endemic Densu
River Valley in the Gar and Eastern Region, 99 sera from people
living in the BU non-endemic Volta Region and 20 sera from
European controls without travel history to Africa (figure 1A).
Based on the defined ELISA OD cut-off values, a sero-positivity
rate of 32% was observed for the sera from the Densu River
Valley. The sero-positivity rate of people living in the Volta
Region (12%), as well as the mean ELISA readouts obtained with
their sera were significantly lower (p,0.001). None of the sera
from European controls exhibited a significant titer (figure 1A).
Sero-positive individuals from the Volta region were re-visited and
interviewed. It was determined that all of them have lived entirely
or at least for most of their life in their home communities in the
Volta Region. One of the sero-positive participants from the
village Torgorme reported at the interview to have a non-healing
chronic wound on the leg (figure 1B). The wound was clinically
diagnosed by an experienced physician as BU and clinical
diagnosis was laboratory reconfirmed by positive IS2404 PCR of
swab specimens. The serum of this reconfirmed BU patient had
the highest anti-18 kDa shsp-specific serum IgG titer of all
participants from the Volta Region tested (figure 1A).
Following the identification of this index case, the health
directorate of the Volta Region sent us specimens from eleven
Sero-Epidemiology of M. ulcerans
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other individuals with suspected BU lesions. Six of these, were
reconfirmed as IS2404 PCR-positive BU by our laboratory at the
Noguchi Memorial Institute for Medical Research, which is one of
the BU reference laboratories in Ghana. While sera of two
laboratory confirmed BU patients contained anti-18 kDa shsp
IgG, four patients were sero-negative.
Comparison of anti-18 kDa shsp IgG sero-positivity in BU
endemic and non-endemic communities along the
Densu River
Active case search surveys were performed to determine the
prevalence of BU along the Densu River (figure 2). The average
prevalence of BU in endemic communities with 3 km buffer was
3.4%. While in some communities upstream no BU cases were
found, the disease burden increases as the River runs downstream
(figure 2A). Of the ten communities included in the
sero-epidemiological study, four (Ntabea, Abesim-Yeboah, Obo-
tanso and Obuotupan) were confirmed as non-endemic, as both
the passive surveillance by the National BU control program and
our active case search identified neither healed nor active cases.
The total prevalence rate, including both healed and active cases,
of the six endemic communities ranged from 1% to 19% with
Tetteh Kofi, Otuaplem and Sode having the highest rates (4.8%,
14.9% and 19.1%, respectively). The prevalence of active cases
ranged from ,1% to 2.4%, with Sode also having the highest
active case prevalence rate.
When 18 kDa shsp-specific serum IgG titers of 295 sera from
BU endemic and of 187 sera from non-endemic communities were
analyzed by ELISA (figure 1A), comparable sero-positivity rates
(33% versus 31%, respectively) were found. ELISA results were
reconfirmed by Western blot analysis with a randomly chosen
subset of sera. There was good agreement between Western blot
Figure 1. Anti-M. ulcerans 18 kDa shsp IgG titers. A OD values of sera from individuals living in BU endemic (E) and non-endemic (NE)
communities along the Densu River (Gar/Eastern) or in the Volta Region (Volta) of Ghana obtained in an 18 kDa shsp ELISA for a 1:100 serum dilution
are shown for individual sera. Sera from Europeans without travel history to Africa served as controls. Statistical differences between groups were
calculated by the Kruskal-Wallis test with Dunn’s post test (*** = p,0.001). B Laboratory confirmed BU lesion of a sero-positive participant from the
Volta region.
doi:10.1371/journal.pntd.0001460.g001
Sero-Epidemiology of M. ulcerans
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band intensities and ELISA titers with a few discrepancies related
to a higher sensitivity of the ELISA method (data not shown).
Sero-responders were found in all age groups (.5 years) tested,
but sero-negative individuals dominated throughout (figure 3).
PCR analysis of environmental samples
211 environmental samples were collected randomly from
both aquatic and dry land environs. The sampled BU endemic
communities included Kojo-Ashong (KA), Sode (SD), Amasa-
man and surrounding hamlets (AS), and Kudeha and surround-
ing hamlets (KD) located in the GW and GS districts. Samples
from non-endemic communities were collected in Abesim-
Yeboah (AY), Obuotumpan (OB) and Ntabea (NB) located in
the EA and NJ districts further up-stream of the Densu River
(figure 2A).
M. ulcerans DNA in an environmental sample was confirmed by
the presence of all three tested loci (IS2404, IS2606 and KR) as
revealed by positive results with all three PCR tests performed. In
all, 19/211 (9.0%) of the samples tested were positive, including 5/
19 aquatic snails, 5/28 sand samples collected from the
communities, 4/30 samples from river water and river bed sand,
2/30 samples from aquatic vegetation, 1/6 sand samples collected
Figure 2. Prevalence of BU and sample collection procedure. A Map showing the prevalence of BU in selected communities along the Densu
River. The prevalence rate was calculated by adding the number of individuals both with active or healed BU lesions divided by the total population
number of the community. Exemplarily, the housing and population census is illustrated for the village Otuaplem. B Photographs illustrating
environmental sampling (a), reconnaissance visit in the communities (b), an active BU lesion found in a community during active search (c) as well as
a healed BU lesion also identified in a community (d).
doi:10.1371/journal.pntd.0001460.g002
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from farms, 1/12 aquatic insects and 1/1 millipedes. As shown in
Table 1 the average positivity rates for samples from endemic
communities were 13.4% (7.7%, 13.3%, 14.3% and 18.5% in KA,
AS, SD and KD, respectively) and 6.2% for samples from non-
endemic communities (26.0%, 2% and 1.8% for NB, OB and AY,
respectively).
Discussion
Broad antigenic cross-reactivity between mycobacterial spe-
cies represents a major challenge for the development of a
serological test that is specific and sensitive enough to monitor
immune responses against M. ulcerans in populations where
exposure to M. tuberculosis and BCG vaccination is common. In
our earlier work, we have identified the M. ulcerans 18 kDa shsp
as an immunodominant antigen, which has no homologues in
M. tuberculosis and M. bovis [10]. However, interspecies cross-
reactivity of this protein with an 18 kDa protein of M. leprae as
well as a 20 kDa protein of M. chelonae was detected. In the same
study we evaluated the use of measuring anti-18 kDa shsp IgG
titers for assessing the exposure of a population to M. ulcerans on
the basis of a limited number of BU patients, household contacts
and people living in areas where BU is not endemic [10]. Since
sera from inhabitants of BU non-endemic regions showed
largely no reactivity with the 18 kDa protein of M. ulcerans,
immune responses against environmental mycobacteria, such as
Figure 3. Age distribution of anti-18 kDa shsp IgG titers. OD values of sera from individuals living in BU endemic (E) and non-endemic (NE)
communities along the Densu River obtained in an 18 kDa shsp ELISA for a 1:100 dilution are shown for individual sera.
doi:10.1371/journal.pntd.0001460.g003
Table 1. IS2404, IS2606, KR PCR positivity of environmental
samples collected in communities along the Densu River.
Village BU endemicity BU prevalence* PCR positivity**
Obuotupan Non-endemic 0% 1/50 (2%)
Abesim Yeboah Non-endemic 0% 1/56 (1.78%)
Ntabea Non-endemic 0% 6/23 (26%)
Amasaman Endemic 5.1% 2/15 (13.3%)
Kudeha Endemic 3.2% 5/27 (18.51%)
Kojo Ashong Endemic 14.3% 2/26 (7.69%)
Sode Endemic 19.1% 2/14 (14.28%)
Total 19/211 (9%)
*Prevalence rate is given as the total prevalence comprising both active and
healed lesions.
**Positivity indicates the presence of all three loci targeted by RT-PC.
doi:10.1371/journal.pntd.0001460.t001
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M. chelonae, do not seem to compromise the developed
serological test for M. ulcerans exposure. Here we have extended
our previous analysis by comparing sera from areas of Ghana,
which rarely report leprosy cases, but differ in their reported BU
endemicity.
In Ghana, a national case search performed in 1999 yielded a
crude national BU prevalence rate of 20.7/100,000 and hence
demonstrated that BU is the second most common mycobac-
teriosis in the country after tuberculosis [13]. In this study
diagnosis of both active and healed lesions was based solely on
clinical grounds without any microbiological confirmation.
Since the creation of the national control program, 32 of the
166 nation-wide districts continuously report BU. Through this
passive surveillance system, over 11,000 cases have been
reported between 1993 and 2006 (http://www.who.int/media-
centre/factsheets/fs199/en/) from mainly six of the ten regions
of Ghana. No BU cases have been reported from the Volta,
Northern, Upper East and West regions, giving the impression
that those four regions do not harbor BU cases and therefore are
non-endemic. However, in our analysis of sera from the Volta
Region, a relatively small, but significant number of serum
samples contained anti-18 kDa shsp IgG. Follow-up visits and
interviews revealed that one of the sero-positive individuals had
a chronic wound which was subsequently laboratory confirmed
as BU [14]. After identification of this index case, additional
laboratory confirmed BU cases were found by active case search
in the Volta Region. In our previous analyses [10], only part of
the sera from laboratory reconfirmed BU patients were tested
postitive for anti-18 kDa shsp IgG. In accordance with these
findings, not all of the BU patient sera from the Volta region
were sero-positive. These data clearly show that anti-18 kDa
shsp IgG titers are no indication for active disease. A large
epidemiological survey is now required to determine the
prevalence of BU over the entire Volta Region. Until today
no serological test allows for a distinction of BU patients and
healthy individuals, which are exposed to M. ulcerans. However,
our results demonstrate that sero-epidemiological studies can be
used to complement active case search in regions, where data
about the BU prevalence are lacking. Future longitudinal sero-
epidemiological studies are planned in order to monitor the
exposure of certain populations to M. ulcerans over a longer
period of time. At this stage we cannot conclude how timing and
frequency of exposure influences antibody titers against the
pathogen.
The prevalence of 18 kDa shsp sero-positive individuals
within populations along the Densu River was .30%. This
confirms our earlier conclusion that a large proportion of
healthy individuals living in endemic communities who have
responded immunologically to M. ulcerans exposure do not
develop overt disease. While the percentage of 18 kDa shsp
sero-positive individuals was higher compared to that found
using a Burulin skin test in healthy controls, it is comparable to
that obtained for the serologic response to M. ulcerans culture
filtrate [15,16]. Diverse outcome of infection with the causative
agents of the main mycobacterial diseases such as tuberculosis
seems to be a common feature of their natural history. Not all
exposed individuals show immunological evidence of infection
and of those who get infected by M. tuberculosis estimations
indicate that only 10% will ever develop overt disease [17,18].
Manifestation of the disease ranges from self-limited pulmonary
infection to localized extra-pulmonary infection and dissemi-
nated disease [19]. Factors accounting for the diversity in
outcomes are not entirely known, but may relate to both host
and pathogen factors. Even though clinical M. ulcerans isolates
from Africa are clonally related and genetically largely
monomorphic [20–27], differences in virulence among African
M. ulcerans strains cannot be ruled out completely. Hence, the
percentage of M. ulcerans infected individuals who proceed to
develop BU remains to be established. BU is known to develop
in all age groups with a nearly equal gender distribution but
most cases occur in children 15 years of age or younger [28]. In
our study we found anti-18 kDa shsp sero-responders in all age
groups (.5 years) analyzed. A future cohort study with infants
could provide important insight, at which age these immune
responses start to emerge.
Both in endemic and non-endemic villages of the Densu River
Valley we found M. ulcerans PCR positive environmental samples.
This is indicative for the presence of M. ulcerans or of closely related
environmental bacteria all along the Densu River. Our findings
are consistent with earlier findings of Williamson et al. [29] in the
same region. Since the mode of M. ulcerans transmission and risk
factors for the exposure to the pathogen are still not entirely
elucidated, it is not clear, whether the types of environmental
samples that were PCR positive have direct relevance for infection
with M. ulcerans. Hence methods for the routine isolation and
characterization of M. ulcerans from the environment need to be
developed.
Hypotheses on risk factors and the mode of infection with M.
ulcerans include contamination of wounds from an environmental
reservoir, inhalation of vaporized contaminated water and
inoculation by insects [30–32]. Our molecular epidemiological
studies have recently demonstrated a focal transmission pattern
for M. ulcerans [27]. This may help to explain one of the mysteries
of BU transmission, the close proximity of endemic and non-
endemic villages. As indicated in figure 2, while M. ulcerans is
endemic in some villages within the Suhum-Kraboa-Coaltar
district, through active case search we did not find any case (both
healed and active) in neighboring districts located at the upper
part of the river, such as East-Akim and the New-Juaben. In
contrast, communities of the four districts, which are situated
downstream (Akwapim South, Akwapim North, Ga-West and
Ga-South) regularly report BU cases. BU endemic and non-
endemic communities along the Densu river differ in terms of
their vegetation. Upstream, within the wet semi-equatorial zone,
the vegetation is predominantly moist semi-deciduous rain forest,
which gradually changes downstream into a short stretch of
Guinea Savannah around Nsawam and ends with coastal scrub
and savannah grassland in the Ga districts. In addition, there is a
variation in the features of the Densu River, which takes its
source from the Atewa Forest Range near Kibi and flows for
116 km into the Weija Water Reservoir before entering the Gulf
of Guinea through the Densu Delta Ramsar site. While upstream
the river flows fast, has clear water and the river bed consists of
rocky stones, downstream the river flows sluggishly, has a muddy
river bed, and the water is turbid. We did not find significant
differences in anti-18 kDa shsp IgG seropositivity rate or titers
between people living in communities in the Densu River Valley
that were classified based on active case search as BU endemic or
non-endemic. These findings could imply at least one of the
following: 1) people in the non-endemic communities in the
upper Densu River Valley may be exposed to M. ulcerans lineages
with low virulence; 2) currently unknown host genetic,
behavioral or socio-economic factors trigger the development
of subclinical M. ulcerans infection to clinical disease; 3) in the
non-endemic communities 18 kDa shsp binding antibodies are
triggered by subclinical infections with environmental mycobac-
teria harboring antigens that are cross-reactive with the 18 kDa
shsp [10].
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